Sign in
Inflammatory and Infectious Diseases Symposium
Annual Meeting Talks
2020
Clinical Experience With the SCS Microinjector for Suprachoroidal Injections by Ophthalmologists
Milan Shah, MD
2019
Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase 2 Study (NEPTUNE)
Robert C. Wang, MD, FASRS
2024
Category: Inflammatory and Infectious Diseases- Helminthic Infections